RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
Lire cette page en: English · العربية · Français · Português
Register / Rwanda / DEA-RW-0000-16076249
Rwanda Food and Drugs Authority · Rwanda
DEA-RW-0000-16076249
Tier 1 · Regulator-publishedClass IRappelStatus · active
Issuing authority
Rwanda Food and Drugs Authority (RWANDAFDA)
Authority reference
Not stated by the issuing authority
Date issued
07 Oct 2021Ambiguous date in the source: could be 2021-10-07 or 2021-07-10. The column is descending, and that does not decide between them. Left unresolved.
Recorded by us
2026-09-06 18:40:27 UTC
Produit
Colosar-Denk 50mg /12,5mg film coated tablet
INN / active substance
Not stated by the issuing authority
Dosage form
Not stated by the issuing authority
Strength
Not stated by the issuing authority
Fabricant
DENK PHARMA
Manufacturer country
Not stated by the issuing authority
MAH or importer
Not stated by the issuing authority
Numéros de lot
Not published with the notice
Dates de péremption
Not published with the notice
Action type
Rappel
Classification
Class I as issued
Indicative severity
Not assessed by Drug Eye Africa
Defect category
Impureté
Product type
Médicament
ATC code
Not stated by the issuing authority
Affected markets
Rwanda — no market beyond the issuing country was named on the notice
Cross-border event
Not linked to a cross-border event
Texte de l’avis
Genotoxic impurity detected in API
Original language: en
Statut
En vigueur
Superseded by
Not superseded. This is the current version.
Version
13

Provenance

Verification tier 1

Where this record came from, and what is held to show it.

Copy of the source
Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.
Ask us for it and check it against the fingerprint below.
Fingerprint
60f6d564c1222b3b6ec906daff230258c238d352b147c51672d47f194babea72
SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
Copy taken
2026-09-11 09:58:19 UTC

Related actions elsewhere

Same stated defect
ReferenceDateCountryProductBatchesActionClassSource
DEA-RW-0000-8646825107 Oct 2021RWLosar-Denk 50 mg film Coated
DENK PHARMA
none publishedRecallClass ITier 1 · Regulator-published
DEA-RW-0000-5154791007 Oct 2021RWLosar-Denk 25 mg film Coated
DENK PHARMA
none publishedRecallClass ITier 1 · Regulator-published
DEA-RW-0000-4094337807 Oct 2021RWColosar-Denk 100 mg /12,5mg film coated tablet
DENK PHARMA
none publishedRecallClass ITier 1 · Regulator-published
DEA-RW-0000-2502079207 Oct 2021RWLosar-Denk 100 mg film Coated
DENK PHARMA
none publishedRecallClass ITier 1 · Regulator-published
DEA-UG-2019-3691610931 Oct 2019UGRanitidinenone publishedImport holdUnclassifiedTier 1 · Regulator-published
Cite this record
Drug Eye Africa (2021). DEA-RW-0000-16076249: Colosar-Denk 50mg /12,5mg film coated tablet — Rappel, Rwanda Food and Drugs Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/rw/2021/dea-rw-0000-16076249

Version history

No version history recorded for this record.
Corrections appear here and in the site-wide log. Records are superseded, never deleted.

Verification

Tier 1Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.

Indexing

This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.